Search results for "càncer"

showing 10 items of 150 documents

Retinoblastoma and mosaic 13q deletion: a case report

2021

Abstract Background Patients with 13q-syndrome are at risk of retinoblastoma when the RB1 gene, located in the chromosomal band 13q14.2, is deleted. This syndrome is frequently associated with congenital malformations and developmental delay, although these signs could be mild. Mosaic 13q-deletion patients have been previously reported in the literature; their phenotype is variable, and they may not be recognized. Case presentation Retinoblastoma diagnosed in a child with 13q-mosaicism confirmed in blood, oral mucosa, healthy retina and retinoblastoma. A second RB1 hit is present exclusively in the retinoblastoma sample (RB1 c.958C>T p.Arg320Ter). Other detected molecular events in retin…

medicine.medical_specialtyPathology13q-syndromeClinodactylyCitogenèticaCase ReportPhysical examinationMalignancyGenètica molecularCytogeneticsMolecular geneticsMedicineMolecular geneticsCàncermedicine.diagnostic_test13q deletion syndromeMosaicismbusiness.industryRetinoblastomaRetinoblastomaCytogeneticsRE1-994medicine.diseasePhenotypeeye diseasesOphthalmologymedicine.symptombusiness
researchProduct

Alcohol-based mouthwash as a risk factor of oral cancer: A systematic review

2019

Background Oral and pharynx cancer represent a serious global problem, reaching an incidence of half a million cases annually. The role of tobacco and alcohol have been studied and proven to be one of its risk factors. We also know that mouthwashes contain a variable percentage of alcohol, so there is a reasonable concern about their role in carcinogenesis. Material and Methods To answer the PICOS (Population; Intervention; Comparison; Outcomes; Study) question: "Do patients (Population) who use alcohol-based mouthwashes (Intervention) compared to those who do not use them (Comparison) have higher acetaldehyde levels in saliva or higher risk of oral cancer development? (Outcomes)" Meta-anal…

medicine.medical_specialtyPopulationMouthwashesReviewCochrane Library03 medical and health sciences0302 clinical medicinestomatognathic systemOral hygieneRisk FactorsInternal medicineHumansMedicineProspective StudiesRisk factoreducationProspective cohort studyGeneral DentistryRetrospective StudiesMouth neoplasmeducation.field_of_studyOral Medicine and Pathologybusiness.industryOral cancerRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Càncer de bocaHigiene bucalSystematic reviewOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASMouth NeoplasmsSurgerybusinessCohort study
researchProduct

Metastatic Versus Osteoporotic Vertebral Fractures on MRI: A Blinded, Multicenter, and Multispecialty Observer Agreement Evaluation.

2020

Background: MRI is assumed to be valid for distinguishing metastatic vertebral fractures (MVFs) from osteoporotic vertebral fractures (OVFs). This study assessed (1) concordance between the image-based diagnosis of MVF versus OVF and the reference (biopsy or follow-up of >6 months), (2) interobserver and intraobserver agreement on key imaging findings and the diagnosis of MVF versus OVF, and (3) whether disclosing a patient’s history of cancer leads to variations in diagnosis, concordance, or agreement. Patients and Methods: This retrospective cohort study included clinical data and imaging from 203 patients with confirmed MVF or OVF provided to 25 clinicians (neurosurgeons, radiologists…

medicine.medical_specialtybusiness.industryConcordanceSpecialtyRetrospective cohort studyRoutine practiceMiddle AgedMagnetic Resonance ImagingCohen's kappaOncologyMulticenter studyDouble-Blind MethodOrthopedic surgeryOssosMedicineHumansFemaleRadiologyNeoplasm MetastasisbusinessCàncerOsteoporotic FracturesRetrospective StudiesJournal of the National Comprehensive Cancer Network : JNCCN
researchProduct

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

2018

Antoni Llueca,1–3 Anna Serra,1–3 José Luis Herraiz,2 Isabel Rivadulla,1,4 Luis Gomez-Quiles,1,4 Juan Gilabert-Estelles,5,6 Javier Escrig1,3,4On behalf of the MUAPOS (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery) working group 1Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery (MUAPOS), University General Hospital of Castellón, Castellón, Spain; 2Department of Obstetrics and Gynecology, University General Hospital of Castellón, Castellón, Spain; 3Department of Medicine, Universitat Jaume I, Castellón, Spain; 4Department of General Surgery, University General Hospital of Castell&…

medicine.medical_specialtyperitoneal cancer indexdiaphragmatic involvementDiaphragmatic breathingcarcinomatosisOncoTargets and Therapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMedicinePeritoneal Carcinomatosis IndexPharmacology (medical)Stage (cooking)CàncerSurvival rateOriginal ResearchAdvanced ovarian canceradvanced ovarian cancerbusiness.industryupper abdominal surgerymedicine.diseaseSurgeryOncology030220 oncology & carcinogenesisConventional PCIPeritoneal Cancer IndexbusinessOvarian cancerOncoTargets and therapy
researchProduct

Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.

2020

Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome. Methods: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT. Results: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and…

medicine.medical_treatmentCàncer d'ovarilcsh:Medicinecomputer.software_genreleikkaushoitoCOLORECTAL-CANCER0302 clinical medicineHormone replacement therapy (female-to-male)munasarjasyöpäMalalties hereditàriesGynecological surgery030219 obstetrics & reproductive medicineManchester Cancer Research CentreDatabaseBrief ReportGeneral MedicineLynch syndrome3. Good healthESTROGENkohdunrungon syöpägynekologiset syövätovarian cancer030220 oncology & carcinogenesisendometrial cancerhormonihoitosyöpätauditHEALTHGenetic disordersGenetic counseling3122 Cancersehkäisevä lääketiede03 medical and health sciencesmedicinerisk-reducing surgeryMedical prescriptionLynchin oireyhtymäperinnölliset tauditHysterectomybusiness.industryResearchInstitutes_Networks_Beacons/mcrcHORMONE REPLACEMENT THERAPYEndometrial cancerlcsh:RInternational survey3126 Surgery anesthesiology intensive care radiologymedicine.diseaseLynch syndromeCàncer d'endometririsk reducing surgerybusinesscomputer
researchProduct

Rational Chemical Multifunctionalization of Graphene Interface Enhances Targeted Cancer Therapy

2020

The synthesis of a drug delivery platform based on graphene was achieved through a step‐by‐step strategy of selective amine deprotection and functionalization. The multifunctional graphene platform, functionalized with indocyanine green, folic acid, and doxorubicin showed an enhanced anticancer activity. The remarkable targeting capacity for cancer cells in combination with the synergistic effect of drug release and photothermal properties prove the great advantage of a combined chemo‐ and phototherapy based on graphene against cancer, opening the doors to future therapeutic applications of this type of material.

multifunctionalizationCarbon materialsCancer therapyAntineoplastic AgentsNanotechnology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciencesCatalysislaw.inventionDrug Delivery SystemslawCell Line TumorNeoplasmsmedicineHumanscancerDoxorubicindiazonium saltsCàncerMaterialsComputingMilieux_MISCELLANEOUSgraphite010405 organic chemistryGrapheneChemistryCancerGeneral MedicineGeneral ChemistryPhotothermal therapymedicine.disease0104 chemical sciencesDrug deliveryCancer cellSurface modificationmedicine.drugAngewandte Chemie International Edition
researchProduct

Desemmascarar el càncer: Centenars de malalties, un sol nom

2013

Tothom té una idea més o menys clara del que representa un càncer: un conjunt de cèl·lules que es divideixen sense control. Darrera aquesta imatge simplista s’amaga un dels problemes de salut més complexes i més greus que existeixen. És gràcies als avenços biomèdics dels últims vint anys que finalment estem reconeixent les grans diferències que hi ha entre els tipus de càncers coneguts, un descobriment que resultarà clau per a dissenyar teràpies més efectives en un futur proper.

p53cáncersupressors tumoralsmedicina; cáncercàncerteràpies personalitzadesGeneral Medicineoncogènmedicinacàncer; oncogèn; p53; supressors tumorals; teràpies personalitzades
researchProduct

Reliability of Frail and Barthel Tests for Detecting Frailty in Palliative Oncological Patients in a Home Hospitalization Unit: A Comparative Study.

2022

Cancer is a condition that can increase the risk of frailty. In addition, palliative oncological patients in home hospitalization can find their activities of daily living affected. The main objective was to measure the degree of frailty in the oncological population in home hospitalization comparing Barthel and Frail-VIG Indexes. This is a descriptive cross-sectional study. A sample of oncological patients in home hospitalization (n = 50) that included 27 men and 23 women were recruited, and disability due to frailty was measured using the VIG frailty index and the Barthel scale for Activities of Daily Living (ADLs). Spearman’s correlation coefficients were categorized as weak (rs &l…

palliative carePaliative careFrailtyHospitalització domiciliàriafrailty; palliative care; cancer; home care; frail-VIG indexPaleontologyCáncerCuidados en casaCuidados paliativosHome careGeneral Biochemistry Genetics and Molecular BiologyOncologíaSpace and Planetary ScienceFrail-VIG indexTractament pal·liatiuÍndice VIG de vulnerabilidadEnfermeríaCàncer Pacientshuman activitiesVulnerabilidadEcology Evolution Behavior and SystematicsCancerLife (Basel, Switzerland)
researchProduct

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer

2022

Simple Summary Non-small cell lung cancer (NSCLC) is the second most commonly diagnosed cancer and the leading cause of cancer-related death worldwide. Clinical decision-making depends on the histological classification; however, tissue biopsy is frequently not technically feasible due to tumor location or limited tissue samples. Therefore, we propose to find clinical, molecular and histological biomarkers using a minimally invasive approach based on the analysis of the cargo of the blood extracellular vesicles. Exosomes are membranous vesicles present in several biological fluids, which carry biological information to distant tissues, regulating several tumor processes. This study aims to …

squamous cell carcinomaCancer ResearchtumorspheresMICRORNASBIOMARKERSCANCER/TESTIS ANTIGENexosomesNSCLCnon-small cell lung cancer; liquid biopsy; exosomes; extracellular vesicles; cell cultures; adenocarcinoma; squamous cell carcinoma; biomarker; tumorspheresMECHANISMSRNASMICROARRAYIMMUNOTHERAPYCàncernon-small cell lung cancerScience & Technologyadenocarcinomaliquid biopsycell culturesSTATISTICSOncologyPulmonsbiomarkerextracellular vesiclesLife Sciences & Biomedicine
researchProduct

Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 coun…

2019

CONCORD Working Group Members: Africa—Algeria: S Bouzbid (Registre du Cancer d’Annaba); M Hamdi-Chérif*, Z Zaidi (Registre du Cancer de Sétif); Gambia: R Swaminathan (National Cancer Registry); Lesotho: SH Nortje (Children’s Haematology Oncology Clinics - Lesotho); Libya: MM El Mistiri (Benghazi Cancer Registry); Mali: S Bayo, B Malle (Kankou Moussa University); Mauritius: SS Manraj, R Sewpaul-Sungkur (Mauritius National Cancer Registry); Nigeria: A Fabowale, OJ Ogunbiyi* (Ibadan Cancer Registry); South Africa: D Bradshaw, NIM Somdyala (Eastern Cape Province Cancer Registry); DC Stefan (Umtata University); Tunisia: L Jaidane, M Mokni (Registre du Cancer du Centre Tunisien).
America (Central…

trendsFunnel plotmedicine.medical_specialtySurvivalPopulationPsychological interventionSocio-culturaleIntrahepatic bile ductsSettore MED/42 - Igiene Generale E Applicataliver cancerhepatocellular carcinoma (HCC)SDG 3 - Good Health and Well-beingInternal medicinemedicinecancer registryeducationSupervivènciaeducation.field_of_studybusiness.industryFetge -- Càncer -- EstadístiquesCancerGeneral MedicineLiver -- Cancer -- Statisticsmedicine.diseasetrendInvasive Malignant NeoplasmHepatocellular carcinomainternational/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLiver cancerbusinesscholangiocarcinomaSurvival trends liver cancer hepatocellular carcinoma (HCC) cholangiocarcinoma cancer registry international
researchProduct